What can your organization do to manage high-cost, innovative therapies now and in the future?
Innovative therapies are bringing new possibilities and hope for populations with rare neuromuscular disease. However, these important advances also come with cost and administrative challenges. The sooner health systems can align with their organizations in managing these challenges, the better for the entire health system. These learnings will then transfer to the many novel agents to come.
This whitepaper outlines actionable ways organizations can:
- Build a business case to gain buy-in for cutting-edge care
- Optimize access through standard operating procedures that align with payer criteria and national guidelines
- Ensure sustainability for a cost-effective, expandable model
Fill out the form to download the whitepaper.